Skip to main content

Advertisement

Table 2 Summary of the prevalence of hepatitis B according to selected studies and biomarkers

From: Epidemiology of viral hepatitis in the Republic of Congo: review

Study Sample size HBsAg prevalence, n (%)* Anti-HBe prevalence, n (%)µ Anti-HBc prevalence, n (%)#
Atipo-Ibarra et al. [22] (1) 1363 9.9   
Angounda et al. [43] (2) 648 6.6 8.2 62.7
Makuwa et al. [83] (3) 334 8.5 4.2 93.6
  1. p value: p (1) → (2) < 0.0192; p (1) → (3) < 0.5*; p (2) → (3) < 0.026µ; p (2) → (3) < 0.00000#; p (2) → (3) < 0.29*